X4 Pharmaceuticals

XFOR

Capitalización de mercado USD 340 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Ikarian Capital Dallas, Texas	USD 17.7 M	+USD 874 k	+3,477	+4%
2	2 Bain Capital Life Sciences Investors Boston, Massachusetts	USD 13.8 M	–	–	–
3	ACM 3 AIGH Capital Management Baltimore, Maryland	USD 9.35 M	+USD 12.1 M	+47,963	Nuevas
4	4 OrbiMed New York	USD 8.93 M	–	–	–
5	5 Vanguard Group Malvern, Pennsylvania	USD 5.83 M	+USD 1.35 M	+5,368	+22%
6	6 BVF Inc San Francisco, California	USD 5.51 M	-USD 2.04 M	-8,123	-22%
7	7 Sio Capital Management New York	USD 5.23 M	–	–	–
8	8 Driehaus Capital Management Chicago, Illinois	USD 5.17 M	–	–	–
9	9 Monashee Investment Management Boston, Massachusetts	USD 3.74 M	–	–	–
10	10 Axa Paris, France	USD 3.7 M	-USD 3.77 k	-15	-0.1%
11	11 Millennium Management New York	USD 2.51 M	+USD 3.24 M	+12,867	Nuevas
12	12 New Leaf Venture Partners New York	USD 2.18 M	–	–	–
13	13 Worth Venture Partners Fort Lee, New Jersey	USD 2.18 M	+USD 2.8 M	+11,156	Nuevas
14	14 Boothbay Fund Management New York	USD 2.13 M	+USD 165 k	+655	+6%
15	15 Polaris Venture Management Co V Boston, Massachusetts	USD 2.02 M	–	–	–
16	16 SV Health Investors Boston, Massachusetts	USD 2.02 M	–	–	–
17	17 BlackRock New York	USD 1.71 M	-USD 6.94 M	-27,616	-76%
18	18 Abingworth London, United Kingdom	USD 1.49 M	–	–	–
19	19 Fidelity Investments Boston, Massachusetts	USD 1.38 M	–	–	–
20	20 Hudson Bay Capital Management Stamford, Connecticut	USD 1.08 M	–	–	–
21	21 Geode Capital Management Boston, Massachusetts	USD 1.05 M	-USD 807 k	-3,209	-37%
22	22 Renaissance Technologies New York	USD 850 k	-USD 212 k	-845	-16%
23	23 Dimensional Fund Advisors Austin, Texas	USD 814 k	+USD 654 k	+2,600	+165%
24	24 Cormorant Asset Management Boston, Massachusetts	USD 676 k	–	–	–
25	25 Prosight Management Dallas, Texas	USD 571 k	+USD 736 k	+2,927	Nuevas

X4 Pharmaceuticals XFOR Capitalización de mercado USD 340 M

X4 Pharmaceuticals

XFOR

Capitalización de mercado USD 340 M